Interim Report January-June 2013 Chrontech Pharma AB
Published: Aug 23, 2013
At the extra general meeting (EGM) in ChronTech Pharma AB on the 16th of May it was resolved to accept the board’s proposal for restructuring of the company and transfer of the Company’s projects regarding development of DNA-vaccines against hepatitis B and hepatitis C.
Help employers find you! Check out all the jobs and post your resume.